Results 231 to 240 of about 154,006 (247)

Alzheimer's Disease

2012
A. Soldan, Y. Gazes, Y. Stern
openaire   +1 more source

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Nature Reviews Drug Discovery, 2010
Harald Hampel, Jessen Frank, Stefan J Teipel   +2 more
exaly  

Alzheimer's disease: strategies for disease modification

Nature Reviews Drug Discovery, 2010
Martin Citron, Citron Martin
exaly  

Drug repositioning for Alzheimer's disease

Nature Reviews Drug Discovery, 2012
Anne Corbett, James Pickett, Alistair Burns   +2 more
exaly  

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

New England Journal of Medicine, 2012
Randall J Bateman, Alison Goate, Nick C Fox   +2 more
exaly  

Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight

Nature Reviews Immunology, 2018
Yang Shi, David M Holtzman, Holtzman David M   +2 more
exaly  

Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease

Nature Reviews Drug Discovery, 2013
Paul S Aisen, Bruno Vellas, Harald Hampel   +2 more
exaly  

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Nature Reviews Drug Discovery, 2011
Eric Karran, Marc Mercken, Bart De Strooper   +2 more
exaly  

Alzheimer's disease

The Lancet, 2002
Burns, Alistair; id_orcid 0000-0002-9837-0645, Byrne, E. Jane, Maurer, Konrad   +2 more
openaire   +3 more sources

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Nature, 2012
Thorlakur Jonsson, Jasvinder K Atwal, Jon Snaedal   +2 more
exaly